Pubblicazioni

Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study  (2022)

Autori:
Bartoli, Francesco; Cavaleri, Daniele; Callovini, Tommaso; Riboldi, Ilaria; Crocamo, Cristina; D'Agostino, Armando; Martinotti, Giovanni; Bertolini, Federico; Ostuzzi, Giovanni; Barbui, Corrado; Carrà, Giuseppe
Titolo:
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study
Anno:
2022
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Formato:
Elettronico
Referee:
Nome rivista:
PSYCHIATRY RESEARCH
ISSN Rivista:
0165-1781
N° Volume:
309
Numero o Fascicolo:
114405
Editore:
Elsevier Science Ireland Limited:PO Box 85, Limerick Ireland:011 353 61 709600, 011 353 61 61944, EMAIL: usinfo-f@elsevier.com, INTERNET: http://www.elsevier.com, Fax: 011 353 61 709114
Intervallo pagine:
1-4
Parole chiave:
Aripiprazole monohydrate; Long-acting injectable antipsychotics; Paliperidone palmitate 1-month
Breve descrizione dei contenuti:
In this prospective study, we assessed the effectiveness and acceptability of paliperidone palmitate 1-month (PP1M) and aripiprazole monohydrate (AM) over 1-year follow-up. We included 195 subjects (117 treated with PP1M and 78 with AM) with schizophrenia spectrum disorders from real-world settings. We estimated no differences in hospitalization (Odds Ratio=1.59; p = 0.12), symptoms improvement (p = 0.90 adjusted for baseline severity), and discontinuation (Hazard Ratio=0.72; p = 0.20) at study endpoint. Although current evidence suggests the possible superiority of AM over PP1M, our findings showed comparable effectiveness between these drugs. Additional studies in real-world settings with direct comparisons between these two LAIs are needed.
Pagina Web:
https://doi.org/10.1016/j.psychres.2022.114405
Id prodotto:
124698
Handle IRIS:
11562/1056869
ultima modifica:
15 novembre 2022
Citazione bibliografica:
Bartoli, Francesco; Cavaleri, Daniele; Callovini, Tommaso; Riboldi, Ilaria; Crocamo, Cristina; D'Agostino, Armando; Martinotti, Giovanni; Bertolini, Federico; Ostuzzi, Giovanni; Barbui, Corrado; Carrà, Giuseppe, Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study «PSYCHIATRY RESEARCH» , vol. 309 , n. 1144052022pp. 1-4

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<indietro

Attività

Strutture

Condividi